Global Nuclear Medicine Industry

• Publication date: November 2012
• Report size: 302 pages

This report analyzes the worldwide markets for Nuclear Medicine in US$ Million by the following Product Segments: Gamma Cameras, and PET Scanners. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. A six-year historic analysis is also provided for these markets. The report profiles 43 companies includ...

This report analyzes the worldwide markets for Nuclear Medicine in US$ Million by the following Product Segments: Gamma Cameras, and PET Scanners. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. A six-year historic analysis is also provided for these markets. The report profiles 43 companies including many key and niche players such as Digirad Corporation, GE Healthcare Plc, Phillips Healthcare, Inc., Positron Corporation, Siemens Medical Solutions USA, Inc., Toshiba Medical Systems Corporation, and Toshiba America Medical Systems, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

Global Medical Imaging Industry

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-2
Quantitative Techniques & Analytics I-3
Product Definitions and Scope of Study I-3
Gamma Cameras I-3
PET Scanners I-4


II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW AND OUTLOOK II-1
Market Snapshots II-1
Nuclear Medicine - An Introduction II-1
Market Witnesses Turbulent Times in Recent Past II-2
Isotope Supply Shock - A Major Factor for Market Decline II-2
Market Rebounds; Brighter Prospects Ahead II-2
Growth Drivers in a Nutshell II-3
Current and Future Analysis II-3
Emerging Markets to Drive Growth; US Still in Spotlight II-4
Susceptibility to Cardiac Disease, Brain Disorders and Cancers
Influence Procedure Volumes II-4
Minimal Impact of Recession on the Medical Contrast Media Market II-4

2. TRENDS AND ISSUES II-5
Global Technetium Shortage Eased II-5
Market Shifts to Hybrid Imaging II-5
PET Eats its Way into Conventional Gamma Camera Market II-6
PET-MRI Emerging as a Promising Standard for Imaging Soft
Tissue Contrast II-6
High Costs - A Major Threat for Market Growth II-6
Technology Innovations Promise Bright Prospects II-7
New Innovations in the Nuclear Medicine Device Market II-7
SPECT/CT Scanners Drive Nuclear Medicine Equipment Market in
North America II-7
Global Nuclear Medicine Market - Historic Statistics II-8
Table 1: Global Gamma Cameras Market (2006): Installed Based
in Units by Select Country - USA, Japan, Canada, and UK
(includes corresponding Graph/Chart) II-8

Table 2: Global PET Scanners Market (2006): Installed Base in
Units by Select Country - USA, Europe, Japan, Germany,
Canada, UK, France, Italy, and Belgium (includes
corresponding Graph/Chart) II-8

3. COMPETITIVE LANDSCAPE II-9
Competition Overview in Nuclear Medicine Market II-9
Table 3: Leading Players in the Global Gamma Camera Market
(2010 & 2011): Percentage Breakdown of Value Sales for
Philips Healthcare, Siemens Healthcare, GE Healthcare, and
Others (includes corresponding Graph/Chart) II-9

Table 4: Leading Players in the Global PET Scanner Market
(2010 & 2011): Percentage Breakdown of Value Sales for
Siemens Healthcare, GE Healthcare, Philips Healthcare and
Others (includes corresponding Graph/Chart) II-10
Leading Players in the Worldwide Nuclear Medicine Market: A
Completive Analysis II-11

4. GLOBAL MEDICAL IMAGING MARKET - AN OVERVIEW II-12
Medical Imaging Changing the Landscape of Clinical Diagnosis II-12
Image-Guided Interventions - Driving Growth in Nuclear
Medicine Arena II-12
Understanding the Concept II-12
Tremendous Market Potential II-12
Clinical Application Areas II-12
Diagnostic Imaging Witnesses Dramatic Growth II-13
Table 5: Global Medical Imaging Market (2010 & 2011):
Percentage Breakdown of Revenues by Imaging Modality - X-Ray,
CT, Ultrasound, MRI and PET & PET/CT (includes corresponding
Graph/Chart) II-14

Table 6: Global Medical Imaging Equipment Installed Based
(2011): Percentage Share Breakdown by Installed Base for
Medical Equipment: X-ray, Ultrasound, Magnetic Resonance,
Computed Tomography, and Nuclear Medicine/PET by
Country/Region (includes corresponding Graph/Chart) II-15
Comparison of Modalities, by Various Imaging Systems II-15
Medical Imaging Equipment Manufacturers Fine Tune Technologies II-16
Future Growth Prospects for Medical Imaging Equipment Market II-16
Multiple Factors Support Global MRI Equipment Market Growth II-16
Reimbursement Remains the Core Issue II-17

5. NUCLEAR MEDICINE - AN INSIGHT II-18
Distinct from General Radiology II-18
History II-18
Major Developments II-19
Nuclear Medicine Scans II-19
Bone Scan II-20
Brain Scan II-20
Gallbladder Scan II-20
Kidney Scan II-21
Liver Scan II-21
Lung Scan II-21
Thyroid Scan II-21
Scrotal Scan II-21
Applications II-22
Cardiac Applications II-22
Neurologic Applications II-22
Oncologic Applications II-22
Orthopedic Applications II-22
Pulmonary Applications II-23
Renal Applications II-23
Other Applications II-23
Estimated Time Allocations for Nuclear Medicine Procedures II-24
Radioisotopes: Essential for Nuclear Medicine Procedure II-24
Radioisotopes Used in Medicine II-25
Clinical Applications of Select Isotopes II-26
Radionuclides in Nuclear Medicine Procedures II-27
Positron-Emitting Radionuclides in PET Procedures II-28

6. NUCLEAR MEDICINE IMAGING EQUIPMENT II-29
Gamma Cameras II-29
Positron Emission Tomography (PET) Scanners II-29
Factors Influencing Growth of PET Scanners II-30
PET & Other Imaging Modalities II-30
Table 7: Comparison of PET and Conventional Imaging
Techniques (includes corresponding Graph/Chart) II-31
Brain Imaging II-32
Alzheimer’s Disease II-32
Brain Trauma II-32
Epilepsy II-32
Heart Imaging II-32
Mobile PET II-33
Parkinson’s Disease II-33
PET & Cancer II-33
PET-CT: An Advancement in Cancer Diagnosis & Treatment II-33

7. RESEARCH AND DEVELOPMENT II-34
Researchers Develop Portable PET Scanner, SynchroPET II-34
Philips and University Medical Center Hamburg- Eppendorf
Develop MRI/PET Imaging Tool II-34
Indian Scientists Develop Low-Cost Nuclear Medicine Kit II-34

8. PRODUCT INNOVATIONS/INTRODUCTIONS II-35
Siemens Healthcare to Unveil Biograph mCT 20 Excel, a PET CT
Imager II-35
MEDX Launches T-Quest™ Gamma Camera II-35
Philips Electronics Introduces GEMINI LXL - A PET/CT Scanner II-35
GE Healthcare Unveils PETtrace 880 - A High Capacity Cyclotron II-36
Royal Philips Launches BrightView X - A Mid-level SPECT Camera II-36
Philips Unveils GEMINI TF PET/CT for Oncology Applications II-36
Siemens Introduces c.cam SPECT System II-36
Positron Introduces PosiRx Solution II-37
Naviscan Unveils High-resolution PET Scanner with PEM Biopsy
Capability II-37
Integrated Modular Systems Releases New Version of imsiPACS
Server II-37

9. RECENT INDUSTRY ACTIVITY II-38
BC Technical Acquires Xpert II-38
GE Healthcare Acquires Orbotech Medical Solutions II-38
Comecer Acquires Veenstra Instruments II-38
Positron Secures Group Purchasing Agreement from Amerinet II-39
GE Healthcare Collaborates with NXT2B II-39
Zecotek Inks Development Deal with NuCare II-39
Siemens Healthcare receives FDA Clearance for Biograph mCT PET
CT Scanner II-40
GE Healthcare Receives US FDA Clearance for Brivo NM615 Gamma
Camera II-40
Digirad Inks Deal with Dilon Diagnostics II-40
Positron Obtains Approval for Marketing Attrius PET scanners
in Canada II-41
Royal Philips Electronics Receives US FDA 510(k) Clearance for
Ingenuity TF PET/MR II-41

10. CORPORATE ACTIVITY IN THE RECENT PAST - A PERSPECTIVE BUILDER II-42
Hybridyne Obtains FDA Clearance for ProxiScanTM Gamma Camera II-42
Digirad Bags FDA Clearance for Portable Imaging System II-42
Digirad Inks Asset Purchase Agreement with MD Office Solutions II-42
Positron Inks Agency Agreement with TIS II-43
Dilon Diagnostics Inks Agreement with Philips Healthcare II-43

11. FOCUS ON SELECT GLOBAL PLAYERS II-44
Digirad Corporation (USA) II-44
GE Healthcare Plc (The United Kingdom) II-44
Phillips Healthcare, Inc. (USA) II-44
Positron Corporation (USA) II-44
Siemens Medical Solutions USA, Inc. (USA) II-45
Toshiba Medical Systems Corporation (Japan) II-45
Toshiba America Medical Systems, Inc. (USA) II-45

12. GLOBAL MARKET PERSPECTIVE II-46
Table 8: World Recent Past, Current & Future Analysis for
Nuclear Medicine by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), and Rest of World
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) II-46

Table 9: World Historic Review for Nuclear Medicine by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), and Rest of World Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2004 through 2009 (includes corresponding Graph/Chart) II-47

Table 10: World 15-Year Perspective for Nuclear Medicine by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and
Rest of World Markets for Years 2004, 2011, & 2018 (includes
corresponding Graph/Chart) II-48
Nuclear Medicine Market by Product Segment II-49
Table 11: World Recent Past, Current & Future Analysis for
Gamma Cameras by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), and Rest of World
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) II-49

Table 12: World Historic Review for Gamma Cameras by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), and Rest of World Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2004 through 2009 (includes corresponding Graph/Chart) II-50

Table 13: World 15-Year Perspective for Gamma Cameras by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and
Rest of World Markets for Years 2004, 2011, & 2018 (includes
corresponding Graph/Chart) II-51

Table 14: World Recent Past, Current & Future Analysis for PET
Scanners by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2010 through 2018 (includes corresponding
Graph/Chart) II-52

Table 15: World Historic Review for PET Scanners by Geographic
Region - US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan), and Rest of World Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2004 through
2009 (includes corresponding Graph/Chart) II-53

Table 16: World 15-Year Perspective for PET Scanners by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and
Rest of World Markets for Years 2004, 2011, & 2018 (includes
corresponding Graph/Chart) II-54


III. MARKET

1. THE UNITED STATES III-1
A.Market Analysis III-1
Current & Future Analysis III-1
Market Snapshots III-1
Nuclear Medicine Market Drivers and Constraints III-2
Noteworthy Trends and Issues III-2
Nuclear Medicine Market in the US Rebounds in 2011 III-2
The US Market for Nuclear Medicine Driven by Hybrid Modalities III-2
Therapeutic Applications to Drive Growth in the US Nuclear
Medicine Market III-3
Market Witnesses Entry of High Value Products III-3
Adoption of SPECT/CT Increasing in the US III-3
PET Procedures in the US Increase III-4
Nuclear Cardiology: Primary Growth Propellant III-4
Dedicated Cardiac PET Scanners - The Future of Nuclear
Cardiology? III-4
Nuclear Medicine Provision Industry Gradually Moves towards
Consolidation III-5
Correlation between Medical Imaging and Nuclear Medicine III-5
Table 17: US Medical Imaging Market (2011): Percentage
Share Breakdown by Segments - X-Ray Imaging, Contrast
Agent and Injector, MRI, Computed Tomography Imaging,
Ultrasound Imaging and Nuclear Medicine (includes
corresponding Graph/Chart) III-6
Competition III-6
Gamma Cameras III-6
Table 18: Market Share of Leading Players in the US Gamma
Camera Market (2010) (includes corresponding Graph/Chart) III-6

Table 19: Market Share of Leading Players in the US Gamma
Camera Market by Cardiology Application (2010) (includes
corresponding Graph/Chart) III-7
PET Scanners III-7
Table 20: Leading Players in the US PET Scanner Market
(2010 & 2011): Percentage Breakdown of Value Sales for
Siemens Medical Solutions, GE Healthcare, Philips
Healthcare, and Others (includes corresponding
Graph/Chart) III-8
Regulatory Overview III-8
Nuclear Regulatory Commission (NRC) III-8
Food and Drug Administration (FDA) III-8
Environmental Protection Agency (EPA) III-8
Centers for Medicare & Medicaid Services (CMS) III-9
Product Launches III-9
Strategic Corporate Developments III-10
Key Players III-12
B.Market Analytics III-14
Table 21: US Recent Past, Current & Future Analysis for
Nuclear Medicine by Product Segment - Gamma Cameras (Single
Head, Dual Head, and Triple Head Cameras) and PET Scanners
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-14

Table 22: US Historic Review for Nuclear Medicine by Product
Segment - Gamma Cameras (Single Head, Dual Head, and Triple
Head Cameras) and PET Scanners Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2004 through 2009 (includes corresponding Graph/Chart) III-15

Table 23: US 15-Year Perspective for Nuclear Medicine -
Percentage Breakdown of Value Sales for Gamma Cameras
(Single Head, Dual Head, and Triple Head Cameras) and PET
Scanners Markets for Years 2004, 2011, & 2018 (includes
corresponding Graph/Chart) III-16

2. CANADA III-17
A.Market Analysis III-17
Current & Future Analysis III-17
Canada Faces Serious Issue over Paucity of PET Scanners III-17
PET Imaging for Cancer Care in Canada - A Long Way to Go III-17
Strategic Corporate Development III-18
B.Market Analytics III-19
Table 24: Canadian Recent Past, Current & Future Analysis
for Nuclear Medicine by Product Segment - Gamma Cameras and
PET Scanners Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2010 through 2018
(includes corresponding Graph/Chart) III-19

Table 25: Canadian Historic Review for Nuclear Medicine by
Product Segment - Gamma Cameras and PET Scanners Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) III-20

Table 26: Canadian 15-Year Perspective for Nuclear Medicine -
Percentage Breakdown of Value Sales for Gamma Cameras and
PET Scanners Markets for Years 2004, 2011, & 2018 (includes
corresponding Graph/Chart) III-21

3. JAPAN III-22
A.Market Analysis III-22
Current & Future Analysis III-22
Market Scenario III-22
Production and Exports of Nuclear Medicine Equipment Suffer
in Japan III-22
Nuclear Medicine Market - Recent Past Statistics III-23
Table 27: PET Scanners and Gamma Cameras Market in Japan
(2008): Installed Base in Units (includes corresponding
Graph/Chart) III-23

Table 28: PET Studies Performed in Japan (2008): Percentage
Breakdown by Type - Tumor, Brain, Heart, and Others
(includes corresponding Graph/Chart) III-23

Table 29: Gamma Cameras Availability in Japan (2007):
Percentage Breakdown by Type - Single Head, Dual Head,
Triple Head, Quadruple Head, and Ring Type (includes
corresponding Graph/Chart) III-23
Toshiba Medical Systems Corporation - A Key Japanese Player III-23
B.Market Analytics III-24
Table 30: Japanese Recent Past, Current & Future Analysis
for Nuclear Medicine by Product Segment - Gamma Cameras and
PET Scanners Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2010 through 2018
(includes corresponding Graph/Chart) III-24

Table 31: Japanese Historic Review for Nuclear Medicine by
Product Segment - Gamma Cameras and PET Scanners Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) III-25

Table 32: Japanese 15-Year Perspective for Nuclear Medicine -
Percentage Breakdown of Value Sales for Gamma Cameras and
PET Scanners Markets for Years 2004, 2011, & 2018 (includes
corresponding Graph/Chart) III-26

4. EUROPE III-27
A.Market Analysis III-27
Current & Future Analysis III-27
Market Overview III-27
Table 33: Leading Therapeutic Areas for Nuclear Medicine
Market in Europe (includes corresponding Graph/Chart) III-28
European Diagnostic Imaging Market III-28
B.Market Analytics III-29
Table 34: European Recent Past, Current & Future Analysis
for Nuclear Medicine by Geographic Region - France, Germany,
Italy, UK, Spain, and Rest of Europe Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2010 through 2018 (includes corresponding Graph/Chart) III-29

Table 35: European Historic Review for Nuclear Medicine by
Geographic Region - France, Germany, Italy, UK, Spain, and
Rest of Europe Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2004 through 2009
(includes corresponding Graph/Chart) III-30

Table 36: European 15-Year Perspective for Nuclear Medicine
by Geographic Region - Percentage Breakdown of Dollar Sales
for France, Germany, Italy, UK, Spain, and Rest of Europe
Markets for Years 2004, 2011, & 2018 (includes corresponding
Graph/Chart) III-31

Table 37: European Recent Past, Current & Future Analysis
for Nuclear Medicine by Product Segment - Gamma Cameras
(Single Head, Dual Head, and Triple Head Cameras) and PET
Scanners Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-32

Table 38: European Historic Review for Nuclear Medicine by
Product Segment - Gamma Cameras (Single Head, Dual Head, and
Triple Head Cameras) and PET Scanners Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2004 through 2009 (includes corresponding Graph/Chart) III-33

Table 39: European 15-Year Perspective for Nuclear Medicine -
Percentage Breakdown of Value Sales for Gamma Cameras
(Single Head, Dual Head, and Triple Head Cameras), and PET
Scanners Markets for Years 2004, 2011, & 2018 (includes
corresponding Graph/Chart) III-34

4a. FRANCE III-35
Market Analysis III-35
Table 40: French Recent Past, Current & Future Analysis for
Nuclear Medicine by Product Segment - Gamma Cameras and PET
Scanners Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-35

Table 41: French Historic Review for Nuclear Medicine by
Product Segment - Gamma Cameras and PET Scanners Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) III-36

Table 42: French 15-Year Perspective for Nuclear Medicine -
Percentage Breakdown of Value Sales for Gamma Cameras and
PET Scanners Markets for Years 2004, 2011, & 2018 (includes
corresponding Graph/Chart) III-37

4b. GERMANY III-38
Market Analysis III-38
Table 43: German Recent Past, Current & Future Analysis for
Nuclear Medicine by Product Segment - Gamma Cameras and PET
Scanners Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-38

Table 44: German Historic Review for Nuclear Medicine by
Product Segment - Gamma Cameras and PET Scanners Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) III-39

Table 45: German 15-Year Perspective for Nuclear Medicine -
Percentage Breakdown of Value Sales for Gamma Cameras and
PET Scanners Markets for Years 2004, 2011, & 2018 (includes
corresponding Graph/Chart) III-40

4c. ITALY III-41
A.Market Analysis III-41
Current & Future Analysis III-41
Strategic Corporate Development III-41
B.Market Analytics III-42
Table 46: Italian Recent Past, Current & Future Analysis for
Nuclear Medicine by Product Segment - Gamma Cameras and PET
Scanners Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-42

Table 47: Italian Historic Review for Nuclear Medicine by
Product Segment - Gamma Cameras and PET Scanners Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) III-43

Table 48: Italian 15-Year Perspective for Nuclear Medicine -
Percentage Breakdown of Value Sales for Gamma Cameras and
PET Scanners Markets for Years 2004, 2011, & 2018 (includes
corresponding Graph/Chart) III-44

4d. THE UNITED KINGDOM III-45
A.Market Analysis III-45
Current & Future Analysis III-45
Market Overview III-45
Table 49: Nuclear Medicine Market in the UK (2011):
Percentage Breakdown of Sales by Technology - Planar
Imaging, SPECT, PET, Non-Diagnostic Imaging, and Therapy
(includes corresponding Graph/Chart) III-45
Strategic Corporate Developments III-46
GE Healthcare Plc - A Key Player in the UK III-46
B.Market Analytics III-47
Table 50: UK Recent Past, Current & Future Analysis for
Nuclear Medicine by Product Segment - Gamma Cameras and PET
Scanners Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-47

Table 51: UK Historic Review for Nuclear Medicine by Product
Segment - Gamma Cameras and PET Scanners Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) III-48

Table 52: UK 15-Year Perspective for Nuclear Medicine -
Percentage Breakdown of Value Sales for Gamma Cameras and
PET Scanners Markets for Years 2004, 2011, & 2018 (includes
corresponding Graph/Chart) III-49

4e. SPAIN III-50
Market Analysis III-50
Table 53: Spanish Recent Past, Current & Future Analysis for
Nuclear Medicine by Product Segment - Gamma Cameras and PET
Scanners Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-50

Table 54: Spanish Historic Review for Nuclear Medicine by
Product Segment - Gamma Cameras and PET Scanners Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) III-51

Table 55: Spanish 15-Year Perspective for Nuclear Medicine -
Percentage Breakdown of Value Sales for Gamma Cameras and
PET Scanners Markets for Years 2004, 2011, & 2018 (includes
corresponding Graph/Chart) III-52

4f. REST OF EUROPE III-53
A.Market Analysis III-53
Current & Future Analysis III-53
Product Launch III-53
B.Market Analytics III-54
Table 56: Rest of Europe Recent Past, Current & Future
Analysis for Nuclear Medicine by Product Segment - Gamma
Cameras and PET Scanners Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2010 through
2018 (includes corresponding Graph/Chart) III-54

Table 57: Rest of Europe Historic Review for Nuclear
Medicine by Product Segment - Gamma Cameras and PET Scanners
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) III-55

Table 58: Rest of Europe 15-Year Perspective for Nuclear
Medicine - Percentage Breakdown of Value Sales for Gamma
Cameras and PET Scanners Markets for Years 2004, 2011, &
2018 (includes corresponding Graph/Chart) III-56

5. ASIA-PACIFIC III-57
A.Market Analysis III-57
Current & Future Analysis III-57
Market Overview III-57
Focus On Select Markets III-57
China III-57
Korea III-57
India III-58
Nuclear Medicine Market in India III-58
Table 59: Installed Base of Nuclear Medicine Scanners in
India in 2011 (includes corresponding Graph/Chart) III-58
India Offers High Growth Potential III-58
Competition III-59
Regulatory Mechanism for Guiding Isotope Production and
Distribution III-59
PET/CT Scanning in India Gathers Momentum III-59
Overview of CT Scanners Market in India III-59
Leading Players in the CT Scan Market III-60
Developments in Clinical Practice and Technology III-60
B.Market Analytics III-61
Table 60: Asia-Pacific Recent Past, Current & Future
Analysis for Nuclear Medicine by Product Segment - Gamma
Cameras and PET Scanners Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2010 through
2018 (includes corresponding Graph/Chart) III-61

Table 61: Asia-Pacific Historic Review for Nuclear Medicine
by Product Segment - Gamma Cameras and PET Scanners Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) III-62

Table 62: Asia-Pacific 15-Year Perspective for Nuclear
Medicine - Percentage Breakdown of Value Sales for Gamma
Cameras and PET Scanners Markets for Years 2004, 2011, &
2018 (includes corresponding Graph/Chart) III-63

6. REST OF WORLD III-64
A.Market Analysis III-64
Current & Future Analysis III-64
Focus on Select Markets III-64
The Middle East III-64
Latin America III-64
B.Market Analytics III-65
Table 63: Rest of World Recent Past, Current & Future
Analysis for Nuclear Medicine by Product Segment - Gamma
Cameras and PET Scanners Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2010 through
2018 (includes corresponding Graph/Chart) III-65

Table 64: Rest of World Historic Review for Nuclear Medicine
by Product Segment - Gamma Cameras and PET Scanners Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) III-66

Table 65: Rest of World 15-Year Perspective for Nuclear
Medicine - Percentage Breakdown of Value Sales for Gamma
Cameras and PET Scanners Markets for Years 2004, 2011, &
2018 (includes corresponding Graph/Chart) III-67


IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 43 (including Divisions/Subsidiaries - (54)

The United States (34)
Canada (1)
Japan (5)
Europe (8)
- Germany (3)
- The United Kingdom (1)
- Italy (2)
- Rest of Europe (2)
Asia-Pacific (Excluding Japan) (5)
Middle East (1)